Clinical Trial Update: Post Marketing Surveillance (PMS) Study of Cresemba in Korea.

View source ↗

Summary

A post-marketing surveillance study of Cresemba (isavuconazole) in Korea has completed, evaluating safety and usage in patients with aspergillosis and mucormyco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis
• Mucormycosis

Drugs mentioned

• Cresemba (isavuconazole)

Snippet

Sponsor: Pfizer | Conditions: Aspergillosis, Mucormycosis | Status: COMPLETED